New SARS-CoV-2 neutralizing antibody in clinical trial now
New SARS-CoV-2 neutralizing antibody in clinical trial now » read more
News Archive
Highly Cited Researchers 2020
Florian and six other scientists of the University of Cologne rank among the Highly Cited Researchers 2020. » read more
Congratulations Christoph and Matthias for identifying potent SARS-CoV-2-neutralizing antibodies
Highly potent neutralizing antibodies in SARS-CoV-2 infected people identified (Cell 07/08/2020). » read more
Congratulations Philipp and Henning for characterizing bNAb 1‑18
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.
(Cell 01/30/2020) » read more
Christoph reviews B Cell Receptor Analyses to Discover Vaccines
Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies (Vaccines 01/01/2020) » read more
Highly Cited Researchers 2019
Florian and four other scientists of the University of Cologne rank among the Highly Cited Researchers 2019. » read more
PostDoc-Award of the Robert‑Koch‑Foundation
Congratulation Henning for receiving the PostDoc-Award of the Robert-Koch-Foundation. » read more
Congratulations Steffi and Matthias for their paper on deciphering the Ebola virus vaccine
Together with our colleagues, Steffi and Matthias decoded the antibody response to the Ebola vaccine rVSVS-ZEBOV.
(Nature Medicine 10/7/2019) » read more
Antibody-mediated HIV-1 Prevention and Therapie
Henning and Florian review the clinical progress of HIV-1 neutralizing antibodies in humans (Retrovirology 11/16/2018) » read more
Combination antibody therapy results in long-term viral suppression in HIV infection
Together with Rockefeller University we demonstrate prolonged viral suppression using two broadly neutralizing antibodies (Nature, 9/26/2018; Nature Medicine 9/26/2018). » read more